# Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus

> **NCT05988216** · NA · RECRUITING · sponsor: **Bioray Laboratories** · enrollment: 12 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **BIOLOGICAL:** BRL-301

## Key facts

- **NCT ID:** NCT05988216
- **Lead sponsor:** Bioray Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-14
- **Primary completion:** 2024-12
- **Final completion:** 2025-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05988216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05988216, "Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05988216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*